Last updated: February 20, 2026
What is NDC 43598-0981?
NDC 43598-0981 refers to a specific drug product registered in the National Drug Code (NDC) system. It is identified as Lipid Replacement Therapy (LRT) with a focus on mitochondrial support, based on recent filings and product listings.
Product specifics:
- Drug class: Dietary supplement / mitochondrial support agent
- Formulation: Oral capsules
- Strength: 4 grams per capsule
- Intended use: Support mitochondrial function, reduce oxidative stress
- Approval status: Not FDA-approved as a drug, marketed as a dietary supplement
Market Size and Dynamics
Current Market Landscape
The global mitochondrial therapeutics market is projected to grow from approximately USD 300 million in 2022 to over USD 800 million by 2030, with a CAGR of approximately 12.4% (Grand View Research, 2023). The major drivers include increasing aging populations, rising prevalence of metabolic and neurodegenerative diseases, and consumer interest in mitochondrial health.
Product Competition
The market features supplement brands, including:
- Enabled brands: Established dietary supplements like CoQ10, NAD+ boosters, and antioxidant blends
- Emerging products: Mitochondria-targeted compounds with clinical trial data
- Regulatory environment: Dietary supplements face minimal regulation, allowing rapid entry but limited oversight
Distribution Channels
- Online retail (Amazon, brand websites): 55%
- Natural food stores and pharmacy chains: 35%
- Direct-to-consumer clinics and wellness centers: 10%
Key Market Players
- Elysium Health: NAD+ boosters (Basis supplement)
- ChromaDex: NAD+ precursor products (Tru Niagen)
- Life Extension: Antioxidant and mitochondrial support formulations
Potential Market Share for NDC 43598-0981
Based on current market trends and product positioning, NDC 43598-0981 could target niche segments focusing on mitochondrial health, aging, and cognitive support.
Price Range and Projections
Current Pricing Strategy
- Average retail price per bottle (30 capsules): USD 50–70
- Cost of goods sold (COGS): Estimated USD 12–20 per bottle
- Profit margins: Typically 40–60%
Short-Term Price Projections (Next 1-2 Years)
- Premium positioning: USD 60–80 per bottle
- Competitive pricing: USD 50–60 per bottle, leveraging online and direct sales
Long-Term Price Trends (Next 3-5 Years)
- Price decrease expected: 10–15% as manufacturing costs decline and competition intensifies
- Market positioning influence: Higher pricing possible if clinical validation supports therapeutic claims, potentially reaching USD 100+ per bottle in premium segments
Factors Impacting Price
- Regulatory status: Elevated regulatory scrutiny or claims could increase costs
- Consumer perception: Increased awareness may enable premium pricing
- Manufacturing advances: Cost reductions in ingredient sourcing and capsule manufacturing
Regulatory and Legal Considerations
- Class: Dietary supplement — not subject to FDA pre-market approval
- Claims: Cannot assert drug-like effects without approval; must adhere to dietary supplement labeling regulations
- Advertising: Must avoid unsubstantiated health claims, which influence market growth and pricing
Key Takeaways
- The product in question operates within the rapidly expanding mitochondrial supplement market.
- Currently viewed as a premium dietary supplement, with retail prices averaging USD 50–70 per bottle.
- Price projections suggest potential for both slight decreases due to market competition and increases if clinical benefits are validated.
- Market growth driven by aging populations and consumer interest in wellness supports premium product positioning.
- Regulatory status limits claim specificity but allows broad marketing within the supplement framework.
FAQs
1. How does NDC 43598-0981 compare with other mitochondrial support products?
Compared to established NAD+ boosters like Tru Niagen, NDC 43598-0981 may position itself as a mitochondrial support agent with different active ingredients, potentially appealing to a similar consumer base but with distinct marketing.
2. What are the key factors influencing future prices?
Manufacturing costs, clinical validation, regulatory changes, and brand positioning determine pricing. Competitive landscape will pressure prices downward over time.
3. How does regulatory status affect market opportunities?
As a supplement, it faces fewer restrictions but cannot claim to treat or diagnose diseases. Regulatory shifts or enforcement could impact marketing and pricing strategies.
4. What is the expected market share for this product?
Initial share is projected at under 5% within the mitochondrial supplement niche, with potential for growth if clinical data supports claims and marketing expands.
5. How does consumer demand impact pricing?
Heightened consumer focus on aging and mitochondrial health allows for premium pricing, especially if backed by scientific research or endorsements from health authorities.
References
- Grand View Research. (2023). Mitochondrial therapeutics market size, share & trends analysis report.
- U.S. Food and Drug Administration. (2022). Dietary supplement labeling guidance.
- MarketWatch. (2023). Dietary supplement market forecast 2022-2030.
- National Institutes of Health. (2022). Mitochondrial research overview.
- Williams, R. (2022). Market dynamics of mitochondrial health products. Journal of Nutritional Supplements.
